We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

GlucoTrack Inc (GCTK) USD0.001

Sell:$2.08 Buy:$2.26 Change: $0.21 (10.70%)
Market closed |  Prices as at close on 4 October 2024 | Switch to live prices |
Sell:$2.08
Buy:$2.26
Change: $0.21 (10.70%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 4 October 2024 | Switch to live prices |
Sell:$2.08
Buy:$2.26
Change: $0.21 (10.70%)
Market closed |  Prices as at close on 4 October 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

GlucoTrack, Inc. is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is developing an implantable continuous glucose monitoring (CGM) for use by Type 1 diabetes patients as well as insulin-dependent Type 2 patients. It is developing an implantable continuous blood glucose monitor (CBGM). This product is designed to have an approximately two-year implant longevity without the requirement for any wearable components. The CBGM utilizes an intravascular approach, in which the device is implanted subcutaneously and connected to a lead that is placed directly into a blood vessel. This facilitates continuous blood glucose measurements with zero lag time. The Company is also developing the Glucotrack CBGM a companion mobile application and a cloud-based solution to provide real time, data-driven personalized tools to effectively help a user manage their diabetes and assist healthcare providers with making treatment decisions.

Contact details

Address:
301 Rt 17 North, Suite 800
RUTHERFORD
07070
United States
Telephone:
+1 (201) 8427715

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
GCTK
ISIN:
US45824Q6061
Market cap:
$12.32 million
Shares in issue:
5.48 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Paul Goode
    Chief Executive Officer, Director
  • James Cardwell
    Chief Financial Officer
  • Drinda Benjamin
    Vice President of Marketing
  • Sandie Martha
    Vice President - Clinical Operations
  • Mark Tapsak
    Vice President of Technology
  • James Thrower
    Vice President - Engineering

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.